journal article·2021-09-22

Hitchhiking Nanoparticles: Mesenchymal Stem Cell-Mediated Delivery of Theranostic Nanoparticles

Dominyka Dapkute, Marijus Pleckaitis, Danute Bulotiene, Dainius Daunoravicius, Ricardas Rotomskis, Vitalijus Karabanovas

ACS Applied Materials & Interfaces· Volume 13· Issue 37
Publisher page

Abstract

Nanotechnology has emerged as a promising solution to permanent elimination of cancer. However, nanoparticles themselves lack specificity to tumors. Due to enhanced migration to tumors, mesenchymal stem cells (MSCs) were suggested as cell-mediated delivery vehicles of nanoparticles. In this study, we have constructed a complex composed of photoluminescent quantum dots (QDs) and a photosensitizer chlorin e6 (Ce6) to obtain multifunctional nanoparticles, combining cancer diagnostic and therapeutic properties. QDs serve as energy donors—excited QDs transfer energy to the attached Ce6 via Förster resonance energy transfer, which in turn generates reactive oxygen species. Here, the physicochemical properties of the QD-Ce6 complex and singlet oxygen generation were measured, and the stability in protein-rich media was evaluated, showing that the complex remains the most stable in protein-free medium. In vitro studies on MSC and cancer cell response to the QD-Ce6 complex revealed the complex-loaded MSCs’ potential to transport theranostic nanoparticles and induce cancer cell death. In vivo studies proved the therapeutic efficacy, as the survival of tumor-bearing mice was statistically significantly increased, while tumor progression and metastases were slowed down.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomedical Physics Laboratory, National Cancer Institute, P. Baublio 3B, 08406 Vilnius, Lithuania

Life Sciences Center, Vilnius University, Sauletekio Ave. 7, 10223 Vilnius, Lithuania

Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Vilnius University, M. K. Ciurlionio 21/27, 03101 Vilnius, Lithuania

Biophotonics Group, Laser Research Centre, Vilnius University, Sauletekio Ave. 10, 10223 Vilnius, Lithuania

Department of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Sauletekio Ave. 11, 10221 Vilnius, Lithuania

Funding

European Regional Development Fund · Lietuvos Moksl?? Akademija · United Nations Educational, Scientific and Cultural Organization · L'Or??al S.A.

References (58)

Show source-provided references
1. 10.1093/jnci/90.12.88910.1093/jnci/90.12.889 ↗
2. 10.1016/s1572-1000(05)00060-810.1016/s1572-1000(05)00060-8 ↗
3. 10.1042/bj2015094210.1042/bj20150942 ↗
4. 10.1016/j.biopha.2018.07.04910.1016/j.biopha.2018.07.049 ↗
5. 10.1111/j.1751-1097.1991.tb02133.x10.1111/j.1751-1097.1991.tb02133.x ↗
6. 10.1038/nphoton.2012.32810.1038/nphoton.2012.328 ↗
7. 10.1021/jacs.8b0294810.1021/jacs.8b02948 ↗
8. 10.1021/acsami.0c2008810.1021/acsami.0c20088 ↗
9. 10.1021/acsami.0c0825510.1021/acsami.0c08255 ↗
10. 10.1021/acsami.8b0851210.1021/acsami.8b08512 ↗
11. 10.1021/acsami.0c2025410.1021/acsami.0c20254 ↗
12. 10.1021/acsami.0c1348910.1021/acsami.0c13489 ↗
13. 10.1016/j.actbio.2018.05.00410.1016/j.actbio.2018.05.004 ↗
14. Valanciunaite J. · 2010 · 7376 · 73760710.1117/12.871524 ↗
15. 10.3390/nano901000910.3390/nano9010009 ↗
16. 10.1021/acsnano.8b0390010.1021/acsnano.8b03900 ↗
17. 10.1016/j.actbio.2019.11.02710.1016/j.actbio.2019.11.027 ↗
18. 10.1016/j.ijpharm.2018.10.01110.1016/j.ijpharm.2018.10.011 ↗
19. 10.7150/jca.1764810.7150/jca.17648 ↗
20. 10.1016/j.biotechadv.2019.01.00610.1016/j.biotechadv.2019.01.006 ↗
21. 10.1016/b978-0-12-416020-0.00014-010.1016/b978-0-12-416020-0.00014-0 ↗
22. 10.2174/15733951079111171810.2174/157339510791111718 ↗
23. 10.7150/thno.1174210.7150/thno.11742 ↗
24. 10.1016/j.cej.2019.12394210.1016/j.cej.2019.123942 ↗
25. 10.1039/c9nr07947e10.1039/c9nr07947e ↗
26. 10.1039/c4ra09998b10.1039/c4ra09998b ↗
27. 10.1007/s10895-012-1146-x10.1007/s10895-012-1146-x ↗
28. 10.1080/1465324060085590510.1080/14653240600855905 ↗
29. 10.1016/j.cellsig.2019.10937710.1016/j.cellsig.2019.109377 ↗
30. 10.7717/peerj.607210.7717/peerj.6072 ↗
31. 10.1039/c6ra00398b10.1039/c6ra00398b ↗
32. 10.2147/ijn.s14336710.2147/ijn.s143367 ↗
33. 10.3762/bjnano.8.12310.3762/bjnano.8.123 ↗
34. 10.1186/s12951-019-0470-610.1186/s12951-019-0470-6 ↗
35. 10.1007/s10812-005-0008-610.1007/s10812-005-0008-6 ↗
36. 10.1093/jmicro/54.suppl_1.i3110.1093/jmicro/54.suppl_1.i31 ↗
37. 10.1021/ja038690510.1021/ja0386905 ↗
38. 10.1038/s41598-017-04650-410.1038/s41598-017-04650-4 ↗
39. 10.1166/jbn.2014.173810.1166/jbn.2014.1738 ↗
40. 10.1016/s1572-1000(05)00030-x10.1016/s1572-1000(05)00030-x ↗
41. 10.3762/bjnano.9.3210.3762/bjnano.9.32 ↗
42. 10.1016/j.jtho.2015.10.02010.1016/j.jtho.2015.10.020 ↗
43. 10.1021/jp301103f10.1021/jp301103f ↗
44. 10.1166/jbn.2014.177010.1166/jbn.2014.1770 ↗
45. 10.1021/ja300537u10.1021/ja300537u ↗
46. 10.1021/acsami.7b1609610.1021/acsami.7b16096 ↗
47. 10.2147/ijn.s3965810.2147/ijn.s39658 ↗
48. 10.1111/xen.1200010.1111/xen.12000 ↗
49. 10.1158/1078-0432.ccr-08-307610.1158/1078-0432.ccr-08-3076 ↗
50. 10.1158/0008-5472.can-04-187410.1158/0008-5472.can-04-1874 ↗
51. 10.18632/oncotarget.2534610.18632/oncotarget.25346 ↗
52. 10.1158/0008-5472.can-10-130510.1158/0008-5472.can-10-1305 ↗
53. 10.1002/stem.55910.1002/stem.559 ↗
54. 10.1038/nnano.2015.33810.1038/nnano.2015.338 ↗
55. 10.1016/j.saa.2017.02.02810.1016/j.saa.2017.02.028 ↗
56. 10.1039/c2cs35392j10.1039/c2cs35392j ↗
57. 10.7150/ntno.2745210.7150/ntno.27452 ↗
58. 10.1007/s10561-014-9471-810.1007/s10561-014-9471-8 ↗